# Epigeneres Biotech

Source: https://onco.cc/companies/epigeneres/  
OnCo record `epigeneres` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A Mumbai company that developed the HrC test, an OCT-4A blood score it says detects and stages cancer.

## Summary

Epigeneres Biotech Pvt Ltd, of Lower Parel, Mumbai, according to its authors' affiliations, developed the HrC test, which scores OCT-4A expression in peripheral blood, and an All Organ Biopsy test; its published support is company-authored.

## Fields

- Kind: Company
- Last checked: 2026-11-03
- Also known as: Epigeneres
- HQ: Mumbai
- Type: diagnostics

## Sources

- Tripathi et al., Stem Cell Reviews and Reports 2021: https://doi.org/10.1007/s12015-021-10167-1

## Connected records

- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/), [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [HrC test (Epigeneres)](https://onco.cc/drugs/hrc-test/)
- key papers: [Quest for Pan-Cancer Diagnosis/Prognosis Ends with HrC Test Measuring Oct4A in Peripheral Blood](https://onco.cc/key-papers/paper-hrc-test-oct4a-stem-cell-rev-2021/)

---
JSON: https://onco.cc/api/v1/entities/epigeneres.json